Additionally, the TNFRI/TNFRII ratio indicated an approximately 8.3 times higher risk of death in COVID-19 patients (OR = 8.3405; CI = 2.4201 to 28.745; p < 0.001) when both variables were considered together (Table 4). This evidence concerns the gene TNFRSF1A and COVID-19.